<!doctype html><html><head><meta charset=utf-8><meta http-equiv=x-ua-compatible content="ie=edge"><meta name=viewport content="width=device-width,initial-scale=1,shrink-to-fit=no"><title>T cells response to CTLA4 and PD-1 checkpoint inhibitors &#183; CoLoMoTo notebooks</title><meta name=description content><link rel=stylesheet href=https://aurelien-naldi.github.io/notebooks/style.main.css></head><body><header><div class=title><a href=https://aurelien-naldi.github.io/notebooks><img src=https://aurelien-naldi.github.io/notebooks/colomoto_banner_white.svg class=logo alt="CoLoMoTo notebooks"></a></div><nav><ul><li><a href=/notebooks/>Home</a></li><li><a href=/notebooks/models/>Models</a></li></ul></nav></header><section><div class=content><h1>T cells response to CTLA4 and PD-1 checkpoint inhibitors</h1><div class=meta><dl><dt>Submitter</dt><dd>A. Naldi</dd><dt>Taxon</dt><dd><span class=keyword>Mammal</span></dd><dt>Process</dt><dd><span class=keyword>Differentiation</span></dd><p class=ref><span class=title>Computational verification of large logical models - application to the prediction of T cell response to checkpoint inhibitors.</span>
<span class=authors>C. Hernandez, A. Naldi, M. Thomas-Chollier, D. Thieffry.</span>
<span class=position></span><span class=year>(2020)</span>.</p></div><p>This comprehensive model integrates the available data on T cell activation,
taking into account CTLA4 and PD-1 checkpoint inhibitory pathways.
It encompasses 216 components and 451 regulatory arcs.</p><p>To ease the verification of the behaviour of this large logical model, we have designed
a modular approach based on a unit testing framework used in software development.
Furthermore, to compare the respective impact of the activation of the two checkpoints,
we have designed a value propagation technique enabling the analytical computation of all
the nodes frozen following the persisting activation or inhibition of any model component.
The model verification approach greatly eased the delineation of logical rules complying with
predefined dynamical specifications, while the use of the value propagation technique provided
interesting insights into the differential potential of CTLA4 and PD-1 immunotherapies.</p><hr><a href="https://mybinder.org/v2/gh/aurelien-naldi/notebooks/master?filepath=models/2020-mammal-tcell-checkpoint-inhibitors/">Open in mybinder</a><h3>Files</h3><ul><li><a href=Hernandez_TcellCheckPoints_13april2020.zginml>Hernandez_TcellCheckPoints_13april2020.zginml</a></li><li><a href=T%20cell%20co-inhibitory%20pathways%20-%20Analysis%20-%2020200429.ipynb>T cell co-inhibitory pathways - Analysis - 20200429.ipynb</a> - <span class="external action"><a href=https://nbviewer.jupyter.org/url/aurelien-naldi.github.io/notebooks//models/2020-mammal-tcell-checkpoint-inhibitors/T%20cell%20co-inhibitory%20pathways%20-%20Analysis%20-%2020200429.ipynb>Preview in nbviewer</a></span></li><li><a href=T%20cell%20co-inhibitory%20pathways%20-%20Unit%20Tests_20200429.ipynb%27>T cell co-inhibitory pathways - Unit Tests_20200429.ipynb'</a> - <span class="external action"><a href=https://nbviewer.jupyter.org/url/aurelien-naldi.github.io/notebooks//models/2020-mammal-tcell-checkpoint-inhibitors/T%20cell%20co-inhibitory%20pathways%20-%20Unit%20Tests_20200429.ipynb%27>Preview in nbviewer</a></span></li></ul></div></section></body></html>